Sort
46,585 grants matching “heart failure”
Endothelial Sphingolipid Synthesis and Tissue Inflammatory Response
$456,803Annarita Di Lorenzo · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
Endothelial Sphingolipid Synthesis and Tissue Inflammatory Response
$456,803Annarita Di Lorenzo · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · HL
Endoglin: A New Target of Therapy for Heart Failure
$456,796Navin Kumar Kapur · Tufts Medical Center · R01 · FY2019 · HL
Endoglin: A New Target of Therapy for Heart Failure
$456,796Navin Kumar Kapur · Tufts Medical Center · R01 · FY2020 · HL
Animal Core
$456,689David Lee Geenen · University Of Illinois At Chicago · P01 · FY2010 · HL
Genetic Determinants of Sodium Retention
$456,661Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2002 · HL
Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitis
$456,591Arnold S Bayer · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2021 · AI
MR DIAGNOSIS OF MUSCLE METABOLISM AND FUNCTION
$456,577University Of Washington · R01 · FY2002 · AR
Molecular Polarization in Dyssynchronous Heart and Cardioresynchronization (CRT)
$456,575Jennifer E Van Eyk · Johns Hopkins University · P01 · FY2008 · HL
RGS14 Regulation of Hormone-sensitive NPT2A-mediated Phosphate Transport
$456,550John R Hepler · Emory University · R01 · FY2022 · GM
Role of FH loss in development of HLRCC heriditary kidney cancer
$456,538Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Chronic Ischemic Mitral Regurgitation: Failure of a Mitral Control System?
$456,529D Craig Miller · Stanford University · R01 · FY2008 · HL
MECHANISM OF ACTION OF VASOPRESSIN
$456,501Massachusetts General Hospital · R37 · FY2000 · DK
Protein quality control in age-related diseases
$456,458Jonathan C. Schisler · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Genetic Modifiers of Congenital Long QT Syndrome
$456,446Vanderbilt University · R01 · FY2005 · HL
Comparative effectiveness analysis of treat-to-target and risk-based blood pressu
$456,381Andrew Edward Moran · Columbia University Health Sciences · R01 · FY2011 · HL
The critical role of the coronary microcirculation in heart failure
$456,333William M Chilian · Northeast Ohio Medical University · R01 · FY2017 · HL
Erythropoietin and trained immunity intransplantation
$456,300Paolo Cravedi · Icahn School Of Medicine At Mount Sinai · R56 · FY2024 · AI
Kidney Function, Aortic Stiffness and Aging
$456,295Andrew S Levey · Tufts Medical Center · R01 · FY2011 · DK
Mechanisms of maternal obesity and feto-placental development in preeclampsia
$456,251Jennifer Liford Sones · Colorado State University · R01 · FY2024 · HD
Role of Depression Medicare Chronic Care Improvement
$456,250Rand Corporation · R01 · FY2005 · MH
Foxp3+ Treg Cells & Primary Graft Dysfunction in Clinical Lung Tx Recipients
$456,242Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2012 · HL
Comparative Safety of Pain Medications
$456,190Cecilia Pilar Chung · Vanderbilt University Medical Center · R01 · FY2021 · AR
Novel surface-modified bioresorbable zinc-based stent materials
$456,085Donghui Zhu · State University New York Stony Brook · R01 · FY2021 · HL
Novel surface-modified bioresorbable zinc-based stent materials
$456,085Donghui Zhu · State University New York Stony Brook · R01 · FY2020 · HL